Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials.
Stefan SchreiberJean-Frederic ColombelBrian G FeaganKristian ReichAtul A DeodharIain B McInnesBrian PorterAyan Das GuptaLuminita PricopTodd FoxPublished in: Annals of the rheumatic diseases (2019)
In this pooled secukinumab safety analysis of 7355 patients across 21 clinical trials, cases of IBD events (including CD, UC and IBDU) were uncommon.